NEW YORK, NY (August 31, 2021) – Michael Zody, PhD, Scientific Director of Computational Biology at the New York Genome Center (NYGC), provided an overview and update of the NYGC’s collaborative SARS-CoV-2 viral surveillance initiatives at a GenomeWeb webinar entitled “Pathogen Surveillance at Scale Using Molecular Inversion Probes.” As part of his presentation, Dr. Zody detailed […]
NEW YORK, NY (October 5, 2021) — The National Institutes of Health (NIH) has selected Hemali Phatnani, PhD, Core Faculty Member and Director, Center for Genomics of Neurodegenerative Disease, New York Genome Center (NYGC), as a recipient of the prestigious NIH Director’s Transformative Research Award. This award is a part of the NIH’s High-Risk, High-Reward […]
NEW YORK, NY (September 17, 2021) — “We have exceeded our wildest expectations, and that is thanks to all of you.” This expression of appreciation from Hemali Phatnani, PhD, Director, Center for Genomics of Neurodegenerative Disease (CGND) at the New York Genome Center (NYGC), kicked off the third (and first virtual) biannual meeting of the […]
NEW YORK, NY (August 30, 2021) – Last year, researchers in the lab of Neville Sanjana, PhD, at the New York Genome Center (NYGC) and New York University (NYU) unveiled a suite of CRISPR-based tools to probe RNA in human cells in a high-throughput fashion using a RNA-targeting CRISPR enzyme (Cas13). Now, as detailed in a […]
NYGC board members, scientists from NYGC member institutions, and NYGC collaborative partners and supporters are also among the honorees recognized as forward-thinking leaders driving the life sciences sector’s growth in New York.
Modified RNA guides improve gene targeting for next-generation CRISPR tools and therapies NEW YORK, NY (August 2, 2021) – In the latest of ongoing efforts to expand technologies for modifying genes and their expression, researchers in the lab of Neville Sanjana, PhD, at the New York Genome Center (NYGC) and New York University (NYU) have developed […]
